Delta Sleep–Inducing Peptide (DSIP) is a short synthetic neuropeptide studied in neuroscience and neuroendocrinology research for its association with sleep regulation and central nervous system signaling. It was originally identified in studies examining sleep-state modulation and has since been explored for its broader role in neurochemical balance.
In laboratory and preclinical research settings, DSIP is examined for its effects on sleep architecture signaling, stress-response pathways, and interactions with neurotransmitter and hormonal systems involved in circadian rhythm regulation. It has also been studied in models exploring neuroprotection, autonomic regulation, and central nervous system homeostasis.
Research involving DSIP focuses on neuropeptide signaling, sleep-related mechanisms, and CNS regulatory pathways rather than therapeutic or clinical application.
